Also, cancerous inhibitor of protein phosphatase 2A (CIP2A) enhances oxidative phosphorylation by promoting tetramer PKM2 formation and redirecting PKM2 to mitochondria, thereby promoting tumor progression (Liang et al., 2024). The gene discussed is PKM; the disease is neoplasm.